No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Lucid Capital Initiates CalciMedica(CALC.US) With Buy Rating, Announces Target Price $13
Comprehensive 2024 Insights Into the Acute Pancreatitis Pipeline Treatment Landscape Featuring CalciMedica, SCM Lifescience, and Lamassu Pharma
CalciMedica to Participate in the Piper Sandler 36th Annual Healthcare Conference
CalciMedica Announces Presentations at Upcoming Medical Meetings
CalciMedica | 10-Q: Q3 2024 Earnings Report
CalciMedica GAAP EPS of -$0.50
No Data